The model for healthcare delivery and treatment was upended by the COVID-19 pandemic, as ordinary Americans have learned to take more control of their own care and treatment, harnessing a new class of technology tools that have given individuals unprecedented clout. But patients and healthcare providers still need to partner together for the best outcomes, according to Jim Weiss, founder and CEO of Real Chemistry.
CrowdPharm, an independent full-service agency with one of healthcare’s largest networks of global talent, announced a strategic partnership with True Media to provide integrated, data-driven media strategy that influences customer behavior.
Global pharmaceutical operations and technology company Biogen partnered with Chinese commercial-stage biopharmaceutical firm InnoCare Pharma to develop a treatment for multiple sclerosis.
ObvioHealth Raises $31 Million, Adds Two Strategic Partners to Bolster Capabilities and Drive Growth Globally NEW YORK, July 1, 2021 /PRNewswire/ — ObvioHealth, a global Virtual Research Organization (VRO), announces it has raised $31 million in its latest round of financing. The round was led by two new partners: Dedalus Group, an international healthcare IT and […]
Doceree Inc., the first global network of physician-only platforms for programmatic marketing, announced the company entered a strategic partnership with Ogilvy Health to enhance the Point of Care campaign offerings available to Ogilvy Health’s clients and partners to advance audience targeting, measurement and reporting capabilities for their marketing initiatives.
Washington D.C.-based global science and technology innovator Danaher announced a definitive agreement to acquire Aldevron for $9.6 billion.
Seattle-based clinical-stage biopharmaceutical company Lumen Bioscience is teaming up with Novo Nordisk to explore research and development opportunities within obesity, among other metabolic disorders.
Lifebit Biotech Ltd. announced the beginning of a long-term partnership with Boehringer Ingelheim to utilize Natural Language Processing (NLP) and Artificial Intelligence (AI) for the detection and early reporting of global disease outbreaks using real-world data harvested from scientific publications and other open sources.
Medable Inc., a leading software platform for patient-centered drug development, announced a partnership with Aural Analytics in the company’s federally funded project to assess remote data capture and digital biomarkers in cancer patients.
Johnson & Johnson decided to terminate a $1.6 billion partnership with Argenx to develop the anti-CD70 antibody cusatuzumab to treat amyotrophic lateral sclerosis (AML) and myelodysplastic syndromes (MDS).
Now, a few years down the road,